• New cancer drug could give hope to non-responsive patients pharmafile
    February 16, 2017
    A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal College of Surgeons in Ireland (RCSI) could be used to treat cancer patients in whom all other treatment avenues have failed.
PharmaSources Customer Service